Tag: Adagio Therapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Adagio Therapeutics Inc.

Playing the long game: Adagio pursues COVID-19 monoclonal antibody development with a $336 ...

Added to Collection on: 2021-04-19 21:56:15

Tags for this article:

Medicine
Medical specialties
Health sciences
Antiviral drugs
COVID-19 drug development
Monoclonal antibodies
COVID-19 vaccine
Medical research
Bamlanivimab
COVID-19
Variants of SARS-CoV-2
Bamlanivimab/etesevimab
Tillman Gerngross
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Adagio Therapeutics sets IPO terms, looks to raise up to $318.6 million

Added to Collection on: 2021-08-02 10:41:15

Tags for this article:

Initial public offering
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Adagio Therapeutics Announces Pricing of Initial Public Offering

Added to Collection on: 2021-08-06 01:30:00

Tags for this article:

Finance
Financial markets
Financial economics
Stock market
Initial public offering
Corporate finance
U.S. Securities and Exchange Commission
Prospectus
Public offering
Forward-looking statement
Security
Securities offering
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Adagio Therapeutics (NASDAQ:ADGI) Stock Rating Upgraded by Morgan Stanley - ETF Daily News

Added to Collection on: 2021-12-03 08:29:59

Tags for this article:

Agios Pharmaceuticals
Life Sciences
Companies
Industry economics)
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Morgan Stanley Lowers Adagio Therapeutics (NASDAQ:ADGI) to Equal Weight - ETF Daily News

Added to Collection on: 2021-12-17 17:17:34

Tags for this article:

Financial markets
Financial economics
Finance
Financial regulation
Short
Initial public offering
Stock
Agios Pharmaceuticals
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Adagio Therapeutics Announces CEO Succession Plan - Yahoo Finance

Added to Collection on: 2022-02-19 06:42:18

Tags for this article:

Clinical trials
COVID-19 vaccination in the United States
RNA vaccines
Medical specialties
Medicine
Life Sciences
BioNTech
Pfizer
Pfizer-BioNTech COVID-19 vaccine
Monoclonal antibody
Forward-looking statement
Moderna COVID-19 vaccine
adagio
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx ...

Added to Collection on: 2022-02-24 19:06:43

Tags for this article:

Life Sciences
Pharmaceutical companies
Economy of New York City
NASDAQ
Economy of the United States
G1 Therapeutics
EMachines
Amicus Therapeutics
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Adagio Therapeutics Reports First Quarter 2022 Financial Results - GuruFocus

Added to Collection on: 2022-06-22 18:07:34

Tags for this article:

Health
Life Sciences
Medical specialties
Biotechnology
Immune system
Immunology
Monoclonal antibody
SARS-CoV-2 Omicron variant
COVID-19 pandemic
Variants of SARS-CoV-2
Moderna COVID-19 vaccine
COVID-19 drug development
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Head to Head Review: Adagio Therapeutics (NASDAQ:ADGI) vs. Alector (NASDAQ:ALEC)

Added to Collection on: 2022-07-03 06:33:54

Tags for this article:

Adagio Therapeutics Inc.
Alector Inc.

Click the tags to see associated articles and topics

View Article Details
Adagio Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights

Added to Collection on: 2022-08-15 11:07:55

Tags for this article:

Economy
Medical specialties
Medicine
Immunology
Asset
Zoonoses
Balance sheet
Retained earnings
Antibody
Cash and cash equivalents
Monoclonal antibody
Equity
adagio
Adagio Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details